Navigation Links
Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
Date:9/19/2008

with age. Clinical severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a more slowly progressive and debilitating osteomalacia in adults.

In the infantile form, infants may appear normal at birth but develop serious symptoms in the first six months of life. These can include failure to thrive, respiratory failure, fractures, and seizures. Radiographic findings include generalized hypomineralization and rickets. Mortality in these patients may be as high as 50%. In the childhood form, patients have varying degrees of hypomineralization, frank rickets, short stature, bone pain, muscle weakness, delayed motor milestones, early loss of deciduous teeth, and may experience frequent, poorly-healing fractures. In the adult form, the underlying osteomalacia causes bone pain due to overt or poorly-healing stress fractures that in some cases stops ambulation.

About ENB-0040

ENB-0040 is a fusion protein that includes the catalytic domain of human tissue non-specific alkaline phosphatase (TNSALP), an immunoglobulin Fc domain and a patented anionic peptide used to target the enzyme to bone. Preclinical studies of ENB-0040 in the "knockout" mouse model of severe hypophosphatasia were recently published in the Journal of Bone and Mineral Research [June 2008:23:777-787] and showed that subcutaneous administration of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations of the disease.

About Enobia Pharma Inc.

Enobia Pharma Inc., is a private, Montreal based company focused on the development of therapeutics to treat serious bone disorders for which there is no currently approved drug therapy. Enzyme Replacement Therapy for the treatment of hypophosphatasia is the Company's lead program. In 2007 Enobia completed a $40M Series B financing lead by OrbiMed Advisors and CTI Life Sciences.

Company Contact:
'/>"/>

SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
3. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
4. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
5. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
6. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
7. Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
8. Vanda Pharmaceuticals Provides Update on Iloperidone
9. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
10. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
11. Addrenex Pharmaceuticals Announces Positive Phase III Clinical Results for Clonicel to Treat ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , 21. November 2014 Michael ... sich am Morgen des 14. Februar 2014 zugetragen hat. ... wohl kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... ich dabei war, mein morgendliches Training zu machen", erzählt ... zu der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. ...
(Date:11/21/2014)...   Coqui RadioPharmaceuticals Corp. , a medical isotope ... of Molybdenum-99 (Mo-99), is proud to announce it has ... design its Medical Isotope Production Facility (MIPF) in ... isotope of Technetium-99, which is used in 80 percent ... legislation making it a national priority to produce Mo-99, ...
(Date:11/21/2014)...   Wellcentive , the industry leader in ... announced today being named one of the four ... .  Sponsored by Intel, the world leader in ... recognizes companies developing leading-edge technology and unique approaches ... Wellcentive,s Mason Beard , senior ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) today announced that the following presentations,will ... formerly XYOTAX(TM)),at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting,May 30 through ... Poster # ... (Abstract#) Sat., ...
... First and Only Treatment for Hunter Syndrome Now Approved in ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May ... company, announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for ...
Cached Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 2Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:11/21/2014)... Launched today on the iTunes App Store, ... care coordination tool designed to make tracking and sharing ... for family members and caregivers (e.g. physicians home care ... caregiver or home health aide providing care for a ... records, goals, schedules, and even final plans in one ...
(Date:11/21/2014)... OXNARD, CA (PRWEB) November 21, 2014 For ... worth the multiple office visits and months of recovery from ... mouth reconstruction – even at the cost of their youthful ... the Anacapa Dental Art Institute in Oxnard and Woodland Hills, ... teeth in one visit, even in instances where the patient’s ...
(Date:11/21/2014)... 21, 2014 Even with years of experience ... learn and room for growth, participating in two recent events ... Farm’s National Convention, a networking event with the leaders of ... bringing back the latest and greatest in insurance news and ... Kirk and his team (Stacy, Anthony, Reina and Jacob) as ...
(Date:11/21/2014)... According to a National Highway Transportation ... 2014, the inflating system found in certain airbags produced ... The force of inflation may cause the metal canister ... may pierce the airbag’s fabric and potentially cause injuries ... to a Bloomberg Business Week article on ...
(Date:11/21/2014)... Salamon HealthDay Reporter ... intellectually challenging tasks may help preserve thinking skills and ... The researchers compared IQ scores obtained around age ... memory and reasoning scores around age 70. The scientists ... to retain sharper thinking even years after retirement. ...
Breaking Medicine News(10 mins):Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3
... Scientists at the leading Swedish medical university Karolinska Institutet ... maintain an appropriate number of ATP sensing ion channel ... in the latest number of Cell Metabolism, explains how ... within the normal range and thereby avoid the development ...
... Firm Ranked Among Inc. ... -, NEW YORK and SAN FRANCISCO, Sept. 5 ... today announced 10 recent new hires to work on several ... Chicago offices. The Company also announced that the 2007 ...
... to Manage ... Menopausal Symptoms, WASHINGTON, Sept. 5 Results from ... since the,release of initial findings from the Women,s Health Initiative (WHI) leave,no ... both,physicians and patients regarding the results of the WHI study. The online,survey ...
... 5 With nationwide recalls of,led-laced baby bibs, led is a ... do with all of this lead information? Now what do I,buy? ... the available bibs?" Bibs,are a necessity; used 5 times everyday for ... can feel safe feeding their children,with the help of a Crumb ...
... lead to tough choices for older Americans, researchers find ... in Medicare plans that charge higher co-pays for brand ... prescriptions than their peers who have a flat co-pay ... The data highlights a tough decision for older Americans: ...
... Doctors Grow as MedHelp Focuses on Answering More ... Consumer Health Questions ... online,health community connecting people to medical experts, information and,shared experiences, ... M.D. and Stephen Ryu, M.D. have joined their,premier roster of ...
Cached Medicine News:Health News:Scientists explain how insulin secreting cells maintain their glucose sensitivity 2Health News:WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business 2Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 2Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 3Health News:One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High 4Health News:Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems 2Health News:High Co-Pays Cause Seniors to Go Without Meds 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 2Health News:MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community 3
... surgery, and the accompanying need for patient ... graft be developed. Grafts must not only ... available in varying sizes and configurations for ... long been the prosthetic of choice among ...
... GORE-TEX Vascular Grafts have met the challenges ... over 25 years. Recognized for exceptional performance ... of renowned surgeons worldwide. These grafts require ... of infection, and assure utmost thrombectomy safety. ...
... Vascular Grafts have met the challenges of ... 25 years. Recognized for exceptional performance and ... renowned surgeons worldwide. These grafts require no ... infection, and assure utmost thrombectomy safety. Gore ...
... Graft, the newest vascular graft offering from ... in vascular surgical products for more than ... kinking and compression problems that can ... provides all of the benefits of a ...
Medicine Products: